Reuters logo
BRIEF-Akcea and Ionis announce filing of new drug submission for Volanesorsen to Health Canada
2017年9月12日 / 晚上8点14分 / 2 个月前

BRIEF-Akcea and Ionis announce filing of new drug submission for Volanesorsen to Health Canada

Sept 12 (Reuters) - Akcea Therapeutics Inc

* Akcea and Ionis announce filing of new drug submission for volanesorsen to Health Canada

* Akcea Therapeutics Inc says ‍Health Canada has also granted priority review for volanesorsen NDS​

* Akcea Therapeutics Inc - We are on track for a potential global commercial launch of volanesorsen in 2018

* Akcea Therapeutics Inc - Akcea plans to file for marketing authorization for volanesorsen to treat FPL in 2019 if data from BROADEN study are positive Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below